Intercell
closedIntercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Post IPO Equity | ||
| Total Funding | 000k | ||
Techno Venture Management(exited)
Star Ventures(exited)
MPM BioImpact(exited)
Global Life Science Ventures(exited)
Apax Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Intercell
EditACQUISITION by Intercell May 2008